3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
2
Phase 2/3
1
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Prostatic Neoplasms
7
Recurrence
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Oropharyngeal Neoplasms
3
Melanoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lung Neoplasms
3
Glioblastoma
3
Gallbladder Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Mouth Neoplasms
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Hyperthermia
2
Interventions
Paclitaxel
1
Letrozole
1
Gonadotropin-Releasing Hormone
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Active not recruiting
×
Carcinoma, Ductal, Breast
×
Clear all
NCT02221999
2023-08-29
SHPD002
RenJi Hospital
Phase 2/3
Active not recruiting
250 enrolled